New Philips ventilator to help free up ICU units in wake of COVID-19
Philips has announced its initiative to quickly scale production of its new Philips Respironics E30 ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations where full-featured, critical care ventilators are not available. The company has begun production immediately, ramping up outputs on an ongoing basis with expectations of producing 15,000 units per week.
“The global situation with the spread of COVID-19 is evolving rapidly. Philips recognizes that in such unprecedented times, acting quickly can make all the difference,” said Özlem Fidancı, chief executive at Philips Middle East and Turkey. “We want to play an integral role in keeping our communities as safe as possible and support people on the frontline. We are happy to announce the successful launch of the Philips Respironics E30 ventilator as a readily available alternative during the COVID-19 crisis here in the Middle East.”
Designed for mass production by a team deeply experienced in respiratory care, the
E30 ventilator features include:
The ability to use the device both invasively and noninvasively; Quick setup and simple operations, allowing health care providers with a wide range of skill sets to treat and monitor patients in clinical and field hospital settings;
The ability to accept high-flow oxygen;
Recommended circuit setups contain a bacterial/viral filter to minimize exposure for health care providers when used invasively or noninvasively with example accessories that may be used, such as a full-face, nonvented (without integrated leak) mask, or helmet; On-screen respiratory monitoring to measure and display vital ventilation type parameters such as pressure, tidal volume, respiratory rate, leak, and oxygen saturation, enabling clinicians to evaluate therapy effectiveness; and
Visual and audible alarms to provide pertinent therapy information to health care providers.
• •
• •
•
•